IBU-TEC ADVANCED MATERIALS A (IBU.DE) Fundamental Analysis & Valuation

FRA:IBU • DE000A0XYHT5

Current stock price

18.6 EUR
-0.25 (-1.33%)
Last:

This IBU.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. IBU.DE Profitability Analysis

1.1 Basic Checks

  • IBU had negative earnings in the past year.
  • In the past year IBU had a positive cash flow from operations.
  • In multiple years IBU reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: IBU reported negative operating cash flow in multiple years.
IBU.DE Yearly Net Income VS EBIT VS OCF VS FCFIBU.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

  • IBU's Return On Assets of -4.02% is on the low side compared to the rest of the industry. IBU is outperformed by 75.71% of its industry peers.
  • IBU's Return On Equity of -5.46% is on the low side compared to the rest of the industry. IBU is outperformed by 72.86% of its industry peers.
Industry RankSector Rank
ROA -4.02%
ROE -5.46%
ROIC N/A
ROA(3y)-3.09%
ROA(5y)-1.54%
ROE(3y)-4.18%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
IBU.DE Yearly ROA, ROE, ROICIBU.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • The Gross Margin of IBU (52.84%) is better than 77.14% of its industry peers.
  • IBU's Gross Margin has declined in the last couple of years.
  • IBU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.97%
GM growth 5Y-1.86%
IBU.DE Yearly Profit, Operating, Gross MarginsIBU.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

8

2. IBU.DE Health Analysis

2.1 Basic Checks

  • IBU does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IBU has about the same amount of shares outstanding.
  • The number of shares outstanding for IBU has been increased compared to 5 years ago.
  • Compared to 1 year ago, IBU has an improved debt to assets ratio.
IBU.DE Yearly Shares OutstandingIBU.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
IBU.DE Yearly Total Debt VS Total AssetsIBU.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • IBU has an Altman-Z score of 3.93. This indicates that IBU is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.93, IBU belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
  • IBU has a debt to FCF ratio of 2.93. This is a good value and a sign of high solvency as IBU would need 2.93 years to pay back of all of its debts.
  • The Debt to FCF ratio of IBU (2.93) is better than 85.71% of its industry peers.
  • IBU has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of IBU (0.17) is better than 68.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.93
Altman-Z 3.93
ROIC/WACCN/A
WACC7.23%
IBU.DE Yearly LT Debt VS Equity VS FCFIBU.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

  • IBU has a Current Ratio of 8.03. This indicates that IBU is financially healthy and has no problem in meeting its short term obligations.
  • IBU's Current ratio of 8.03 is amongst the best of the industry. IBU outperforms 98.57% of its industry peers.
  • IBU has a Quick Ratio of 3.15. This indicates that IBU is financially healthy and has no problem in meeting its short term obligations.
  • IBU has a Quick ratio of 3.15. This is amongst the best in the industry. IBU outperforms 94.29% of its industry peers.
Industry RankSector Rank
Current Ratio 8.03
Quick Ratio 3.15
IBU.DE Yearly Current Assets VS Current LiabilitesIBU.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. IBU.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 53.84% over the past year.
  • Looking at the last year, IBU shows a decrease in Revenue. The Revenue has decreased by -6.21% in the last year.
  • IBU shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.88% yearly.
EPS 1Y (TTM)53.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.21%
Revenue 1Y (TTM)-6.21%
Revenue growth 3Y4.71%
Revenue growth 5Y0.88%
Sales Q2Q%-23.52%

3.2 Future

  • The Earnings Per Share is expected to grow by 28.60% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 21.36% on average over the next years. This is a very strong growth
EPS Next Y91.04%
EPS Next 2Y38.35%
EPS Next 3Y28.6%
EPS Next 5YN/A
Revenue Next Year-11.59%
Revenue Next 2Y-8.09%
Revenue Next 3Y4.93%
Revenue Next 5Y21.36%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IBU.DE Yearly Revenue VS EstimatesIBU.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 2031 50M 100M 150M
IBU.DE Yearly EPS VS EstimatesIBU.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1

1

4. IBU.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • IBU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IBU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IBU.DE Price Earnings VS Forward Price EarningsIBU.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IBU is valued a bit more expensive than 71.43% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as IBU.
Industry RankSector Rank
P/FCF 30.85
EV/EBITDA 33.56
IBU.DE Per share dataIBU.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • IBU's earnings are expected to grow with 28.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.35%
EPS Next 3Y28.6%

1

5. IBU.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.18%, IBU is not a good candidate for dividend investing.
  • IBU's Dividend Yield is slightly below the industry average, which is at 2.38.
  • With a Dividend Yield of 0.18, IBU pays less dividend than the S&P500 average, which is at 1.91.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IBU.DE Yearly Dividends per shareIBU.DE Yearly Dividends per shareYearly Dividends per share 2019 2023 0.05 0.1 0.15

5.3 Sustainability

DP0%
EPS Next 2Y38.35%
EPS Next 3Y28.6%
IBU.DE Yearly Income VS Free CF VS DividendIBU.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

IBU.DE Fundamentals: All Metrics, Ratios and Statistics

IBU-TEC ADVANCED MATERIALS A

FRA:IBU (3/13/2026, 7:00:00 PM)

18.6

-0.25 (-1.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A
Earnings (Next)04-13
Inst Owners3.32%
Inst Owner ChangeN/A
Ins Owners48.12%
Ins Owner ChangeN/A
Market Cap88.35M
Revenue(TTM)44.78M
Net Income(TTM)-2.78M
Analysts83.33
Price Target28.25 (51.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)264.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)82.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-0.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.97
P/FCF 30.85
P/OCF 11.15
P/B 1.74
P/tB 1.92
EV/EBITDA 33.56
EPS(TTM)-0.58
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)0.6
FCFY3.24%
OCF(TTM)1.67
OCFY8.97%
SpS9.43
BVpS10.69
TBVpS9.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.02%
ROE -5.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.84%
FCFM 6.4%
ROA(3y)-3.09%
ROA(5y)-1.54%
ROE(3y)-4.18%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.97%
GM growth 5Y-1.86%
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.93
Debt/EBITDA 2.96
Cap/Depr 113.35%
Cap/Sales 11.3%
Interest Coverage N/A
Cash Conversion 279.37%
Profit Quality N/A
Current Ratio 8.03
Quick Ratio 3.15
Altman-Z 3.93
F-Score6
WACC7.23%
ROIC/WACCN/A
Cap/Depr(3y)170.7%
Cap/Depr(5y)144.35%
Cap/Sales(3y)15.86%
Cap/Sales(5y)13.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.21%
EPS Next Y91.04%
EPS Next 2Y38.35%
EPS Next 3Y28.6%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.21%
Revenue growth 3Y4.71%
Revenue growth 5Y0.88%
Sales Q2Q%-23.52%
Revenue Next Year-11.59%
Revenue Next 2Y-8.09%
Revenue Next 3Y4.93%
Revenue Next 5Y21.36%
EBIT growth 1Y64.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year215.13%
EBIT Next 3Y59.66%
EBIT Next 5YN/A
FCF growth 1Y122.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2881.05%
OCF growth 3YN/A
OCF growth 5Y17.1%

IBU-TEC ADVANCED MATERIALS A / IBU.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for IBU-TEC ADVANCED MATERIALS A?

ChartMill assigns a fundamental rating of 4 / 10 to IBU.DE.


What is the valuation status for IBU stock?

ChartMill assigns a valuation rating of 1 / 10 to IBU-TEC ADVANCED MATERIALS A (IBU.DE). This can be considered as Overvalued.


How profitable is IBU-TEC ADVANCED MATERIALS A (IBU.DE) stock?

IBU-TEC ADVANCED MATERIALS A (IBU.DE) has a profitability rating of 1 / 10.


How financially healthy is IBU-TEC ADVANCED MATERIALS A?

The financial health rating of IBU-TEC ADVANCED MATERIALS A (IBU.DE) is 8 / 10.